Go Pro

Maven Income and Growth VCT 4 (MAV4) Competitors

Maven Income and Growth VCT 4 logo
GBX 47.60 -0.90 (-1.86%)
As of 08/5/2026 08:20 AM Eastern

MAV4 vs. ANII, PCFC, BRFI, BIOG, and SMIF

Should you buy Maven Income and Growth VCT 4 stock or one of its competitors? MarketBeat compares Maven Income and Growth VCT 4 with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Maven Income and Growth VCT 4 include abrdn New India Investment Trust (ANII), Polar Capital Global Financials Trust (PCFC), BlackRock Frontiers (BRFI), The Biotech Growth Trust (BIOG), and TwentyFour Select Monthly Income Fund (SMIF). These companies are all part of the "asset management & custody banks" industry.

How does Maven Income and Growth VCT 4 compare to abrdn New India Investment Trust?

Maven Income and Growth VCT 4 (LON:MAV4) and abrdn New India Investment Trust (LON:ANII) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Maven Income and Growth VCT 4 has a net margin of -28.12% compared to abrdn New India Investment Trust's net margin of -2,108.76%. Maven Income and Growth VCT 4's return on equity of 0.57% beat abrdn New India Investment Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Maven Income and Growth VCT 4-28.12% 0.57% -0.11%
abrdn New India Investment Trust -2,108.76%-24.12%15.37%

Maven Income and Growth VCT 4 has a beta of 0.04891589, indicating that its stock price is 95% less volatile than the broader market. Comparatively, abrdn New India Investment Trust has a beta of 0.291, indicating that its stock price is 71% less volatile than the broader market.

In the previous week, abrdn New India Investment Trust had 2 more articles in the media than Maven Income and Growth VCT 4. MarketBeat recorded 2 mentions for abrdn New India Investment Trust and 0 mentions for Maven Income and Growth VCT 4. abrdn New India Investment Trust's average media sentiment score of 2.00 beat Maven Income and Growth VCT 4's score of 0.00 indicating that abrdn New India Investment Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Maven Income and Growth VCT 4 Neutral
abrdn New India Investment Trust Very Positive

abrdn New India Investment Trust has lower revenue, but higher earnings than Maven Income and Growth VCT 4. abrdn New India Investment Trust is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 4, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maven Income and Growth VCT 4£1.04M76.48£1.33M£0.32148.75
abrdn New India Investment Trust-£88.86M-3.56£116.72M-£184.74N/A

23.0% of abrdn New India Investment Trust shares are held by institutional investors. 1.8% of Maven Income and Growth VCT 4 shares are held by company insiders. Comparatively, 1.1% of abrdn New India Investment Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Maven Income and Growth VCT 4 beats abrdn New India Investment Trust on 7 of the 13 factors compared between the two stocks.

How does Maven Income and Growth VCT 4 compare to Polar Capital Global Financials Trust?

Polar Capital Global Financials Trust (LON:PCFC) and Maven Income and Growth VCT 4 (LON:MAV4) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

Maven Income and Growth VCT 4 has lower revenue, but higher earnings than Polar Capital Global Financials Trust. Polar Capital Global Financials Trust is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 4, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Polar Capital Global Financials Trust£70.33M0.00N/A£49.50N/A
Maven Income and Growth VCT 4£1.04M76.48£1.33M£0.32148.75

Polar Capital Global Financials Trust has a net margin of 0.00% compared to Maven Income and Growth VCT 4's net margin of -28.12%. Maven Income and Growth VCT 4's return on equity of 0.57% beat Polar Capital Global Financials Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Polar Capital Global Financials TrustN/A N/A N/A
Maven Income and Growth VCT 4 -28.12%0.57%-0.11%

In the previous week, Polar Capital Global Financials Trust's average media sentiment score of 0.00 equaled Maven Income and Growth VCT 4'saverage media sentiment score.

Company Overall Sentiment
Polar Capital Global Financials Trust Neutral
Maven Income and Growth VCT 4 Neutral

Summary

Polar Capital Global Financials Trust beats Maven Income and Growth VCT 4 on 4 of the 6 factors compared between the two stocks.

How does Maven Income and Growth VCT 4 compare to BlackRock Frontiers?

Maven Income and Growth VCT 4 (LON:MAV4) and BlackRock Frontiers (LON:BRFI) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

Maven Income and Growth VCT 4 has a beta of 0.04891589, indicating that its stock price is 95% less volatile than the broader market. Comparatively, BlackRock Frontiers has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market.

BlackRock Frontiers has higher revenue and earnings than Maven Income and Growth VCT 4. BlackRock Frontiers is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 4, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maven Income and Growth VCT 4£1.04M76.48£1.33M£0.32148.75
BlackRock Frontiers£81.92M3.86£73.42M£41.784.60

8.0% of BlackRock Frontiers shares are owned by institutional investors. 1.8% of Maven Income and Growth VCT 4 shares are owned by insiders. Comparatively, 0.5% of BlackRock Frontiers shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Maven Income and Growth VCT 4 pays an annual dividend of GBX 5.50 per share and has a dividend yield of 11.6%. BlackRock Frontiers pays an annual dividend of GBX 10.01 per share and has a dividend yield of 5.2%. Maven Income and Growth VCT 4 pays out 1,718.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. BlackRock Frontiers pays out 24.0% of its earnings in the form of a dividend.

In the previous week, Maven Income and Growth VCT 4's average media sentiment score of 0.00 equaled BlackRock Frontiers'average media sentiment score.

Company Overall Sentiment
Maven Income and Growth VCT 4 Neutral
BlackRock Frontiers Neutral

BlackRock Frontiers has a net margin of 284.82% compared to Maven Income and Growth VCT 4's net margin of -28.12%. BlackRock Frontiers' return on equity of 15.49% beat Maven Income and Growth VCT 4's return on equity.

Company Net Margins Return on Equity Return on Assets
Maven Income and Growth VCT 4-28.12% 0.57% -0.11%
BlackRock Frontiers 284.82%15.49%13.46%

Summary

BlackRock Frontiers beats Maven Income and Growth VCT 4 on 9 of the 13 factors compared between the two stocks.

How does Maven Income and Growth VCT 4 compare to The Biotech Growth Trust?

Maven Income and Growth VCT 4 (LON:MAV4) and The Biotech Growth Trust (LON:BIOG) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation.

10.5% of The Biotech Growth Trust shares are held by institutional investors. 1.8% of Maven Income and Growth VCT 4 shares are held by insiders. Comparatively, 3.0% of The Biotech Growth Trust shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, The Biotech Growth Trust had 1 more articles in the media than Maven Income and Growth VCT 4. MarketBeat recorded 1 mentions for The Biotech Growth Trust and 0 mentions for Maven Income and Growth VCT 4. The Biotech Growth Trust's average media sentiment score of 1.45 beat Maven Income and Growth VCT 4's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Maven Income and Growth VCT 4 Neutral
The Biotech Growth Trust Positive

Maven Income and Growth VCT 4 has a beta of 0.04891589, meaning that its stock price is 95% less volatile than the broader market. Comparatively, The Biotech Growth Trust has a beta of 0.587836, meaning that its stock price is 41% less volatile than the broader market.

The Biotech Growth Trust has a net margin of 96.47% compared to Maven Income and Growth VCT 4's net margin of -28.12%. The Biotech Growth Trust's return on equity of 48.26% beat Maven Income and Growth VCT 4's return on equity.

Company Net Margins Return on Equity Return on Assets
Maven Income and Growth VCT 4-28.12% 0.57% -0.11%
The Biotech Growth Trust 96.47%48.26%12.39%

The Biotech Growth Trust has higher revenue and earnings than Maven Income and Growth VCT 4. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 4, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maven Income and Growth VCT 4£1.04M76.48£1.33M£0.32148.75
The Biotech Growth Trust£133.86M2.42£83.83M£558.003.01

Summary

The Biotech Growth Trust beats Maven Income and Growth VCT 4 on 11 of the 13 factors compared between the two stocks.

How does Maven Income and Growth VCT 4 compare to TwentyFour Select Monthly Income Fund?

Maven Income and Growth VCT 4 (LON:MAV4) and TwentyFour Select Monthly Income Fund (LON:SMIF) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

15.1% of TwentyFour Select Monthly Income Fund shares are held by institutional investors. 1.8% of Maven Income and Growth VCT 4 shares are held by company insiders. Comparatively, 0.2% of TwentyFour Select Monthly Income Fund shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Maven Income and Growth VCT 4 has higher earnings, but lower revenue than TwentyFour Select Monthly Income Fund. TwentyFour Select Monthly Income Fund is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 4, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maven Income and Growth VCT 4£1.04M76.48£1.33M£0.32148.75
TwentyFour Select Monthly Income Fund£17.70M17.36N/A£5.7514.99

Maven Income and Growth VCT 4 has a beta of 0.04891589, meaning that its stock price is 95% less volatile than the broader market. Comparatively, TwentyFour Select Monthly Income Fund has a beta of 0.6692135, meaning that its stock price is 33% less volatile than the broader market.

In the previous week, TwentyFour Select Monthly Income Fund had 1 more articles in the media than Maven Income and Growth VCT 4. MarketBeat recorded 1 mentions for TwentyFour Select Monthly Income Fund and 0 mentions for Maven Income and Growth VCT 4. TwentyFour Select Monthly Income Fund's average media sentiment score of 0.75 beat Maven Income and Growth VCT 4's score of 0.00 indicating that TwentyFour Select Monthly Income Fund is being referred to more favorably in the news media.

Company Overall Sentiment
Maven Income and Growth VCT 4 Neutral
TwentyFour Select Monthly Income Fund Positive

Maven Income and Growth VCT 4 pays an annual dividend of GBX 5.50 per share and has a dividend yield of 11.6%. TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.2%. Maven Income and Growth VCT 4 pays out 1,718.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

TwentyFour Select Monthly Income Fund has a net margin of 57.51% compared to Maven Income and Growth VCT 4's net margin of -28.12%. TwentyFour Select Monthly Income Fund's return on equity of 5.95% beat Maven Income and Growth VCT 4's return on equity.

Company Net Margins Return on Equity Return on Assets
Maven Income and Growth VCT 4-28.12% 0.57% -0.11%
TwentyFour Select Monthly Income Fund 57.51%5.95%N/A

Summary

TwentyFour Select Monthly Income Fund beats Maven Income and Growth VCT 4 on 10 of the 14 factors compared between the two stocks.

Get Maven Income and Growth VCT 4 News Delivered to You Automatically

Sign up to receive the latest news and ratings for MAV4 and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MAV4 vs. The Competition

MetricMaven Income and Growth VCT 4Capital Markets IndustryFinance SectorLON Exchange
Market Cap£79.70M£5.65B£14.14B£2.87B
Dividend Yield4.33%7.46%5.91%6.13%
P/E Ratio148.7537.9029.19369.22
Price / Sales76.481,252.53513.1483,799.94
Price / Cash3.0748.2339.3227.89
Price / Book0.753.713.737.09
Net Income£1.33M£417.17M£1.31B£5.89B
7 Day PerformanceN/A1.19%1.18%1.20%
1 Month Performance-2.86%-0.53%0.53%0.93%
1 Year Performance-5.74%6.69%13.29%75.25%

Maven Income and Growth VCT 4 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MAV4
Maven Income and Growth VCT 4
N/AGBX 47.60
-1.9%
N/A-9.3%£79.70M£1.04M148.75N/A
ANII
abrdn New India Investment Trust
N/AGBX 738
+1.4%
N/A-6.5%£318.29M-£88.86MN/AN/A
PCFC
Polar Capital Global Financials Trust
N/AN/AN/AN/A£315.13M£70.33M2.09N/A
BRFI
BlackRock Frontiers
N/AGBX 191.73
+0.9%
N/A+16.0%£313.44M£81.92M4.59N/A
BIOG
The Biotech Growth Trust
N/AGBX 1,622
+2.1%
N/A+101.9%£312.12M£133.86M2.91N/A

Related Companies and Tools


This page (LON:MAV4) was last updated on 8/6/2026 by MarketBeat.com Staff.
From Our Partners